Compare Immunovant Inc. Common Stock (IMVT) vs Hyperliquid Strategies Inc Common Stock (PURR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Hyperliquid Strategies Inc Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.5 (market cap $6.25B), while Hyperliquid Strategies Inc Common Stock trades at $11.14 (market cap $2.24B). The key difference: Immunovant Inc. Common Stock is far larger — about 2.8× Hyperliquid Strategies Inc Common Stock's market cap, and Hyperliquid Strategies Inc Common Stock is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 1 Days and Hyperliquid Strategies Inc Common Stock for 1 Days on average.
| IMVT | PURR | |
|---|---|---|
Market Cap | $6.25B | $2.24B |
Volume | 1,755,411 | 14,135,020 |
Sector | Health | Financials |
52-Week High | $44.96 | $14.09 |
52-Week Low | $17.03 | $3.10 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $5.35B | $2.10B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Hyperliquid Strategies Inc Common Stock
Hyperliquid Strategies is a digital asset treasury company focused on managing a treasury of HYPE tokens, the native digital assets of the Hyperliquid Layer-1 blockchain.
Read more on PURR →
